Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals

• US 5,965,789 A
• Filed: 05/04/1995
• Issued: 10/12/1999
• Est. Priority Date: 01/11/1991
• Status: Expired due to Term

• Current Assignee: The American Red Cross
• Original Assignee: The American Red Cross
• Inventors: Paleyanda, Rekha K., Drohan, William N., Lubon, Henryk
• Primary Examiner(s): Crouch, Deborah
• Application Number:
  US08/434,834
• Time in Patent Office: 1,622 Days
• Field of Search: 800/2, 800/7, 800/14, 536/23.1, 536/24.1, 435/320.1, 435/240.2, 435/172.3, 435/69.1, 435/69.6
• US Class Current: 800/14
• CPC Class Codes: A01K 2207/15 Humanized animals
• CPC Class Codes: A01K 2217/00 Genetically modified animals
• CPC Class Codes: A01K 2217/05 Animals comprising random inserted nucleic acids (transgenic)
• CPC Class Codes: A01K 2227/10 Mammal
• CPC Class Codes: A01K 2227/105 Murine
• CPC Class Codes: A01K 2267/01 Animal expressing industrially exogenous proteins
• CPC Class Codes: A01K 67/0278 Knock-in vertebrates, e.g. humanised vertebrates
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: C07K 14/75 Fibrinogen
• CPC Class Codes: C07K 2319/00 Fusion polypeptide
• CPC Class Codes: C07K 2319/02 containing a signal sequence
• CPC Class Codes: C12N 15/64 General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
• CPC Class Codes: C12N 15/67 General methods for enhancing the expression
• CPC Class Codes: C12N 15/8216 Methods for controlling, regulating or enhancing expression of transgenes in plant cells
• CPC Class Codes: C12N 15/8243 involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
• CPC Class Codes: C12N 15/85 for animal cells
• CPC Class Codes: C12N 15/8509 for producing genetically modified animals, e.g. transgenic
• CPC Class Codes: C12N 2830/008 cell type or tissue specific enhancer/promoter combination
• CPC Class Codes: C12N 2830/85 mammalian
• CPC Class Codes: C12N 9/6454 Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
• CPC Class Codes: C12N 9/6464 : Protein C (3.4.21.69)
• CPC Class Codes: C12Y 304/21069 : Protein C activated (3.4.21.69)

Abstract

The invention relates to transgenic non-human multicellular organisms that contain polynucleotides for expressing proteins that alter posttranslational modification. In particular, the invention provides multiply-transgenic animals in which a first transgene encodes a first protein, a second transgene encodes a second protein, and expression of the second protein affects the posttranlational modification of the first protein in cells of said organism. Expression in preferred embodiments is in specific cells and the modified protein is secreted into a bodily fluid. The invention provides related methods, proteins and products. An example provides transgenic animals that express human Protein C and the processing protease PACE/furin in mammary glands and secrete both proteins into milk.

Claims

1. A non-human transgenic mammal which produces a post-translationally modified first protein, wherein said mammal comprises somatic and germ cells having stably incorporated into the genome of said cells, a first exogenous polynucleotide encoding a first protein susceptible to modification by PACE/furin and a second exogenous polynucleotide encoding PACE/furin, each of said first and second exogenous polynucleotides operatively linked to a mammary epithelial cell specific promoter, and wherein said mammal expresses said first exogenous polynucleotide and said second exogenous polynucleotide in the mammary gland epithelial cells, wherein said PACE/furin post-translationally modifies said first protein, such that said modification results in a post-translationally modified first protein.

2. The non-human transgenic mammal according to claim 1, wherein said post-translational modification is required for maturation of said first protein.

3. The non-human transgenic mammal according to claim 1, wherein said first polynucleotide encodes a precursor protein and said precursor protein is modified by said PACE/furin.

4. The non-human transgenic mammal according to claim 3, wherein said first protein is Factor VII, Factor VIII, Factor IX, prothrombin, Factor X, Protein C, Protein S, bone Gla protein, matrix Gla protein, growth arrest specific protein 6, antithrombin III, t-PA, erythropoietin, fibrinogen, immunoglobulin or albumin.

5. The non-human transgenic mammal according to claim 1, wherein said first protein is a vitamin-K dependent protein.

6. The non-human transgenic mammal according to claim 1, wherein said first protein is Factor VII, Factor VIII, Factor IX, prothrombin, Factor X, Protein C, Protein S, bone Gla protein, matrix Gla protein, growth arrest specific protein 6, antithrombin III, t-PA, erythropoietin, fibrinogen, immunoglobutin or albumin.

7. The non-human transgenic mammal according to claim 1, wherein said first polynucleotide encodes Protein C.

8. The non-human transgenic mammal according to claim 1, wherein said first protein is Factor VIII.

9. The non-human transgenic mammal according to claim 1, wherein said first protein is Factor IX.

10. The non-human transgenic mammal according to claim 1, wherein said first protein is fibrinogen.

11. The non-human transgenic mammal according to claim 1, further comprising a third exogenous polynucleotide operatively linked to a mammary epithelial cell specific promoter that encodes a third protein, which gamma-carboxylates said first protein.

12. The non-human transgenic mammal according to claim 11, wherein said first polynucleotide encodes Protein C.

13. The transgenic non-human mammal according to claim 1, wherein said mammal is selected from the group consisting of mice, rats, hamster, guinea pigs, rabbits, pigs, sheep, goats and cows.

14. A method for producing a post-translationally modified first protein in a non-human transgenic mammal, wherein said mammal comprises somatic and germ cells having stably incorporated into the genome of said cells, a first exogenous polynucleotide encoding a first protein susceptible to modification by PACE/furin and a second exogenous polynucleotide encoding PACE/furin, each of said first and second exogenous polynucleotides operatively linked to a mammary epithelial cell specific promoter, wherein said method comprises expressing said first exogenous polynucleotide and said second exogenous polynucleotide in the mammary gland eptithelial cells, and wherein said PACE/furin post-translationally modifies said first protein, such that said modification results in a post-translationally modified first protein, and obtaining said post-translationally modified first protein from the milk of said mammal.

15. The method according to claim 14, wherein said post-translational modification is required for maturation of said first protein.

16. The method according to claim 14, wherein said first polynucleotide encodes a precursor protein and said precursor protein is modified by said PACE/furin.

17. The method according to claim 14, wherein said post-translationally modified first protein is secreted by said mammary gland epithelial cells into milk of said mammal.

18. The method according to claim 14, wherein at least one of said first protein or said PACE/furin is secreted into said milk of said mammal.

19. The method according to claim 14, wherein said first protein is a vitamin-K dependent protein.

20. The method according to claim 14, wherein said first protein is Factor VII, Factor VIII, Factor IX, prothrombin, Factor X, Protein C, Protein S, bone Gla protein, matrix Gla protein, growth arrest specific protein 6, antithrombin III, t-PA, erythropoietin, fibrinogen, immunoglobulin or albumin.

21. The method according to claim 14, wherein said first polynucleotide encodes Protein C.

22. The method according to claim 14, wherein said first protein is Factor VIII.

23. The method according to claim 14, wherein said first protein is Factor IX.

24. The method according to claim 14, wherein said first protein is fibrinogen.

25. The method according to claim 14, further comprising a third exogenous polynucleotide operatively linked to a mammary epithelial cell specific promoter that encodes a third protein, which gamma-carboxylates said first protein.

26. The method according to claim 25, wherein said first polynucleotide encodes Protein C.

27. The method according to claim 14, wherein said mammal is selected from the group consisting of mice, rats, hamster, guinea pigs, rabbits, pigs, sheep, goats and cows.